Bicycle Therapeutics
Bicycle Therapeutics, a pioneering biotechnology company headquartered in Cambridge, GB, is at the forefront of developing innovative therapies using its proprietary Bicycle platform. Founded in 2009, the company focuses on creating a new class of medicines known as Bicycles, which are designed to target and treat a range of diseases, including cancer and autoimmune disorders.
With a strong emphasis on precision medicine, Bicycle Therapeutics has achieved significant milestones, including strategic partnerships and advancing multiple candidates into clinical trials. Their unique approach combines the benefits of small molecules and biologics, positioning them as a leader in the biopharmaceutical industry. As they continue to expand their operational reach, Bicycle Therapeutics remains committed to transforming patient outcomes through cutting-edge therapeutic solutions.
-19 vs industry average
Bicycle Therapeutics’s score of 21 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Bicycle Therapeutics?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has typical carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Bicycle Therapeutics yet.
Bicycle Therapeutics's reported carbon emissions
Bicycle Therapeutics, headquartered in Great Britain, currently does not have any reported carbon emissions data. As such, there are no specific figures available for their Scope 1, Scope 2, or Scope 3 emissions. Additionally, the company has not outlined any reduction targets or climate commitments, nor are there any initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges documented.
In the absence of emissions data and reduction initiatives, it is important to note that many organisations in the biotechnology sector are increasingly focusing on sustainability and carbon neutrality. Bicycle Therapeutics may consider adopting similar strategies to align with industry standards and expectations regarding climate action.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Bicycle Therapeutics’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Bicycle Therapeutics yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Bicycle Therapeutics
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project